These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34135561)

  • 1. Prediction of hepatic inflammation in chronic hepatitis B patients with a random forest-backward feature elimination algorithm.
    Zhou JY; Song LW; Yuan R; Lu XP; Wang GQ
    World J Gastroenterol; 2021 Jun; 27(21):2910-2920. PubMed ID: 34135561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients.
    Li MR; Lu JH; Ye LH; Sun XL; Zheng YH; Liu ZQ; Zhang HC; Liu YY; Lv Y; Huang Y; Dai EH
    Medicine (Baltimore); 2016 Aug; 95(34):e4422. PubMed ID: 27559949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum qAnti-HBc combined with ALT and HBsAg predicts significant hepatic inflammation in HBeAg-positive immune active patients.
    Wang X; Gao X; Wu R; Chi X; Xu H; Guan Y; Jin Q; Niu J
    J Gastroenterol Hepatol; 2022 Sep; 37(9):1806-1814. PubMed ID: 35509262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum hepatitis B core antibody titer use in screening for significant fibrosis in treatment-naïve patients with chronic hepatitis B.
    Li MR; Zheng HW; Lu JH; Ma SM; Ye LH; Liu ZQ; Zhang HC; Liu YY; Lv Y; Huang Y; Dai EH; Sun DX
    Oncotarget; 2017 Feb; 8(7):11063-11070. PubMed ID: 28052021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response relationship between qAnti-HBc and liver inflammation in chronic hepatitis B with normal or mildly elevated alanine transaminase based on liver biopsy.
    Zhang C; Liu Y; Li J; Liu H; Shao C; Liu D; Yu M; Xi H; Zhao H; Wang G
    J Med Virol; 2022 Aug; 94(8):3911-3923. PubMed ID: 35419853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between serum hepatitis B surface antigen and hepatitis B core antibody titers and liver fibrosis in treatment-naïve CHB patients.
    Li MR; Zheng HW; Ma SM; Liu YY; Qie LX; Li JQ; Wang DH; Sun XL; Ren GF; Zheng YH; Wang YL; Dai EH
    J Chin Med Assoc; 2018 Dec; 81(12):1052-1059. PubMed ID: 30143430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of quantitative hepatitis B core antibody levels in predicting significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase levels.
    Li J; Zhang TY; Song LW; Qi X; Yu XP; Li FH; Zhou P; Qin YL; Yang L; Zhao JH; Mao RC; Zhang YM; Wang JY; Yang FF; Zhu HX; Yang SS; Huang YX; Yuan Q; Zhang J; Zhang JM; Xia NS
    Hepatol Res; 2018 Feb; 48(3):E133-E145. PubMed ID: 28707778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase.
    Zhou J; Song L; Zhao H; Yan L; Ma A; Xie S; Zhang X; Zhang D; Xie Q; Zhang G; Shang J; Cheng J; Zhao W; Zou Z; Zhang M; Xia N; Wang G
    Sci Rep; 2017 Jun; 7(1):2747. PubMed ID: 28584279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of anti-HBc quantification in hepatitis B virus related acute-on-chronic liver failure.
    Li J; Gong QM; Xie PL; Lin JY; Chen J; Wei D; Yu DM; Han Y; Zhang XX
    J Gastroenterol Hepatol; 2021 May; 36(5):1291-1299. PubMed ID: 33091955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of quantitative hepatitis B core antibody (qHBcAb) and aspartate aminotransferase (AST) can accurately diagnose immune tolerance of chronic hepatitis B virus infection based on liver biopsy.
    Chi Z; Zhao W; Li JW; Liu H; Shao C; Zhao H; Gui-Qiang W
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101563. PubMed ID: 33272888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of qAnti-HBc with antiviral efficacy in children with chronic hepatitis B and exploration of its possible immune mechanism].
    Zhou YZ; Chang YN; He Y; Wang HM; Peng XR; Chen M; Peng ML; Hu P; Ren H; Xu HM
    Zhonghua Gan Zang Bing Za Zhi; 2021 Sep; 29(9):837-843. PubMed ID: 34638201
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of anti-HBc and liver inflammation in HBeAg-negative chronic hepatitis B virus-infected patients with normal ALT and detectable HBV DNA.
    Yao K; Wang J; Wang L; Xia J; Yan X; Wu W; Liu J; Wang L; Yin S; Tong X; Ding W; Huang R; Wu C
    J Med Virol; 2022 Feb; 94(2):659-666. PubMed ID: 34499353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
    Li N; Xu JH; Yu M; Wang S; Si CW; Yu YY
    World J Gastroenterol; 2015 Nov; 21(43):12421-9. PubMed ID: 26604649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel noninvasive index for the prediction of moderate to severe fibrosis in chronic hepatitis B patients.
    Li J; Mao RC; Li XL; Zheng JW; Qi X; Yuan Q; Zhang J; Zhang JM; Xia NS
    Dig Liver Dis; 2018 May; 50(5):482-489. PubMed ID: 29396134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of serum HBsAg levels, HBsAg/HBV DNA ratio, and association with liver inflammation activity in HBeAg-positive chronic hepatitis B].
    Li G; Wang J; Bao Y; Zheng L; Ge K; Zhou X; Chen G
    Zhonghua Gan Zang Bing Za Zhi; 2015 Jan; 23(1):40-5. PubMed ID: 25751385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical noninvasive markers for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase less than two times upper limit of normal.
    Wu Z; Dong X; Wang G; Zhao H;
    J Viral Hepat; 2019 Feb; 26(2):287-296. PubMed ID: 30380162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.
    Ormeci A; Aydın Y; Sumnu A; Baran B; Soyer OM; Pınarbasi B; Gokturk S; Gulluoglu M; Onel D; Badur S; Akyuz F; Karaca C; Demir K; Besisik F; Kaymakoglu S
    Int J Infect Dis; 2016 Nov; 52():68-73. PubMed ID: 27619844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
    Li Q; Li W; Huang Y; Chen L
    J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum alkaline phosphatase levels as a simple and useful test in screening for significant fibrosis in treatment-naive patients with hepatitis B e-antigen negative chronic hepatitis B.
    Hu J; Zhang X; Gu J; Yang M; Zhang X; Zhao H; Li L
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):817-823. PubMed ID: 30543572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic characteristics of liver inflammation and fibrosis in 310 patients with chronic hepatitis B.
    Jiang C; Liu J; Li R; Chen K; Peng W; Fu L; Peng S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):698-706. PubMed ID: 37539572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.